| HOME >> BIOLOGY >> TECHNOLOGY |
31,537
4,778Intangible asset, net
26,297
25,569
3,874Available-for-sale equity securities
48,475
50,763
7,691Other investment
-
135,528
20,535Deferred tax assets
288
1,209
183Total assets1,047,034
1,371,778
207,845LIABILITIESCurrent liabilitiesBank loan
45,000
45,000
6,818Accounts payable
5,410
9,569
1,450Accrued expenses and other payables
22,475
21,715
3,290Deferred revenue
36,074
58,242
8,825Amounts due to related parties
2,977
682
103Income tax payable
4,098
8,023
1,216Total current liabilities116,034
143,231
21,702Deferred revenue
93,155
138,328
20,959Other non-current liabilities
15,978
25,121
3,806Deferred tax liabilities
2,259
-
-Total liabilities 227,426
306,680
46,467EQUITYShareholders' equityOrdinary shares - US$0.0001 par value, 250,000,000 shares authorized, 66,743,693 shares and 75,406,875 shares issued and outstanding as of March 31 and December 31, 2010, respectively
46
52
8Additional paid-in capital
719,329
910,316
137,927Accumulated other comprehensive income/(loss)
2,221
(18,992)
(2,878)Retained earnings
87,290
152,734
23,141Total shareholders' equity 808,886
1,044,110
158,198Noncontrolling interests10,722
20,988
3,180Total equity819,608
1,065,098
161,378Total liabilities and equity1,047,034
1,371,778
207,845Exhibit 2CHINA CORD BLOOD CORPORATIONUNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONSFor the Three Months and Nine Months Ended December 31, 2009 and 2010Three months ended December 31,
Nine months ended December 31,2009
2010
200
'/>"/>
| SOURCE China Cord Blood Corporation Copyright©2010 PR Newswire. All rights reserved |